Research / AVGO / Fundamental state Inspectable configuration
State dimensions Filing 0001730168-21-000153 General Corporate
Debt relative to revenue 7th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.debt_to_revenue
144.50% · OPTIONAL · VALID
Capex intensity 0th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.61% · OPTIONAL · VALID
Operating cash generation 62th Own-history percentile · N=13
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
50.14% · OPTIONAL · VALID
Revenue growth 80th Own-history percentile · N=10
Evidence method Yoy · gp.fundamentals.revenue
14.91% · CORE · VALID
Inventory pressure 14th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
4.72% · OPTIONAL · VALID
Gross margin 86th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.gross_margin
61.36% · CORE · VALID
Operating margin 93th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.operating_margin
31.03% · CORE · VALID
R&D intensity 0th Own-history percentile · N=14
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
17.68% · OPTIONAL · VALID
SBC intensity 14th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
6.21% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 23 states Self-history eligible
Feb 3, 2019 0/8 normalized Level 3 May 5, 2019 0/9 normalized Level 3 Aug 4, 2019 0/9 normalized Level 3 Nov 3, 2019 0/9 normalized Level 3 Feb 2, 2020 0/9 normalized Level 3 May 3, 2020 6/9 normalized Level 3 Aug 2, 2020 8/9 normalized Level 3 Nov 1, 2020 8/9 normalized Level 3 Jan 31, 2021 8/9 normalized Level 3 May 2, 2021 9/9 normalized Level 3 Aug 1, 2021 9/9 normalized Level 3 Oct 31, 2021 9/9 normalized Level 3 Jan 30, 2022 9/9 normalized Level 3 May 1, 2022 9/9 normalized Level 3 Jul 31, 2022 9/9 normalized Level 3 Oct 30, 2022 8/8 normalized Level 3 Jan 29, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 30, 2023 8/8 normalized Level 3 Aug 2, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 596.03%
Current 144.50%
Delta -451.53% Capex Intensity Decreased
Previous 1.70%
Current 1.61%
Delta -0.08% Cash Generation Decreased
Previous 52.24%
Current 50.14%
Delta -2.10% Growth Decreased
Previous 16.44%
Current 14.91%
Delta -1.53% Inventory Pressure Decreased
Previous 17.11%
Current 4.72%
Delta -12.39% Margin Decreased
Previous 61.92%
Current 61.36%
Delta -0.56% Profitability Decreased
Previous 31.37%
Current 31.03%
Delta -0.33% R And D Intensity Decreased
Previous 17.78%
Current 17.68%
Delta -0.10% Sbc Intensity Decreased
Previous 6.21%
Current 6.21%
Delta -0.00% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.